CA 15-3 also
known as
cancer
breast
antigens is
used mainly
to monitor a
person's
response to
breast
cancer
treatment
and to watch
for breast
cancer
recurrence.
CA 15-3 is
sometimes
ordered to
have a
general
sense of how
much cancer
may be
present (the
tumor
burden). CA
15-3 can
only be used
as a marker
if the
cancer is
producing
elevated
amounts of
it, so this
test will
not be
useful for
all breast
cancer
patients.
CA 15-3 may
be ordered
along with
other tests,
such as
estrogen and
progesterone
receptors,
Her2/neu,
and gene
expression
tests for
breast
cancer, when
advanced
breast
cancer is
first
diagnosed to
help
determine
cancer
characteristics
and
treatment
options. If
CA 15-3 is
initially
elevated,
then it may
be ordered
periodically
to monitor
the
effectiveness
of treatment
and to
detect
recurrence.
CA 15-3 is
usually not
ordered when
breast
cancer is
detected
early,
before it
has
metastasized,
because
levels will
not be
elevated in
the majority
of early
cancers.
Back to top